Genetic Stability Analysis

Comprehensive Genetic Stability Analysis Services – Ensuring Product Consistency, Safety, and Regulatory Compliance for Biopharmaceuticals and Cell‑Based Therapies

The demonstration of genetic stability is a fundamental requirement for the development and manufacturing of biopharmaceutical products, including recombinant proteins, monoclonal antibodies, vaccines, gene therapies, and cell‑based therapeutics. Genetic stability ensures that the production cell line maintains its identity, productivity, and safety attributes over multiple passages, from the master cell bank (MCB) to the limit of in‑vitro cell age used for production. Regulatory authorities, including the FDA, EMA, and ICH, require comprehensive genetic stability studies as part of the product characterisation and comparability packages (ICH Q5B, Q5D, and Q6B). However, a robust genetic stability strategy is not a one‑size‑fits‑all approach; it must be tailored to the cell type (e.g., CHO, HEK293, Vero, or stem cells), the vector system (e.g., plasmid, viral, or transposon), the integration site and copy number, and the intended clinical application. The analysis must detect any genetic changes that could affect product quality, safety, or efficacy, including point mutations, insertions, deletions, rearrangements, copy number variations (CNVs), and chromosomal aberrations. Furthermore, regulatory expectations are moving towards higher‑resolution techniques, such as whole‑genome sequencing (WGS), optical genome mapping (OGM), and digital PCR (dPCR), to replace or complement traditional methods like Southern blot and karyotyping. Our ISO/IEC 17025‑accredited and GMP‑compliant laboratory offers a fully integrated genetic stability testing platform, encompassing a comprehensive suite of analytical methods – from targeted assays (e.g., qPCR, Southern blot, STR profiling) to high‑resolution genome‑wide approaches (e.g., WGS, array‑CGH, OGM). We deliver quantitative, traceable data, expert interpretation, and full regulatory support, enabling you to demonstrate the genetic stability of your cell line and to meet the strictest regulatory requirements with confidence.

1. The Scientific and Regulatory Rationale for Genetic Stability Testing

Genetic stability is assessed to ensure that the cell line does not accumulate detrimental genetic alterations during prolonged culture, which could lead to loss of productivity, altered product quality (e.g., glycosylation profile, aggregation), or even tumorigenicity. Regulatory guidelines (ICH Q5B, Q5D, and Q5E) require that the genetic stability of the production cell line be established by testing the MCB, the working cell bank (WCB), and cells at or beyond the population doubling level used for production (the limit of in‑vitro cell age). The selection of the appropriate analytical methods depends on the type of expression system: for CHO cells, methods should detect vector copy number, integration site, and any rearrangements; for viral vectors, the integrity of the transgene and the absence of replication‑competent viruses must be confirmed; for stem cells, karyotype and telomere length analysis are critical. The choice of method – whether low‑resolution (karyotyping, FISH), medium‑resolution (array‑CGH, STR analysis), or high‑resolution (WGS, OGM) – must be justified based on the product’s risk profile and the regulatory guidance. Our service begins with a comprehensive consultation to design a genetic stability testing plan that is scientifically sound, regulatory‑compliant, and tailored to your specific cell line and manufacturing process.

2. Our Comprehensive Genetic Stability Testing Platform – Targeted and Genome‑Wide Approaches

We maintain a complete suite of validated genetic stability testing methods, all performed in a dedicated molecular biology laboratory with strict quality controls, and with certified reference materials and controls. Our portfolio includes:

2.1 Southern Blot Analysis – Copy Number and Integration Site Integrity
We perform Southern blotting to determine the transgene copy number and to detect any large‑scale rearrangements or deletions in the integrated vector. We use restriction digestion, gel electrophoresis, and hybridisation with labelled probes specific to the transgene and to the flanking genomic regions. The method is validated for sensitivity (detecting copy number changes) and specificity (distinguishing between different integration events). We provide a detailed banding pattern and a copy number estimate, with a clear interpretation of the integrity of the integration locus.

2.2 qPCR and Digital PCR (dPCR) – Copy Number Quantification and Stability Over Passages
We use quantitative PCR (qPCR) and droplet digital PCR (ddPCR) to accurately quantify the transgene copy number and the copy number of the vector backbone (to detect any loss or amplification). We include a reference gene (e.g., a housekeeping gene) for normalisation, and we perform the assay on samples from different passages to monitor stability over time. The ddPCR method provides absolute quantification without the need for a standard curve, with a precision that is superior to qPCR, particularly for low copy numbers. We report the copy number per cell, the coefficient of variation (CV) across replicates, and any trend over passages.

2.3 Short Tandem Repeat (STR) Profiling – Cell Line Identity and Clonality
We perform STR profiling using a multiplex PCR system that targets multiple STR loci (e.g., CODIS markers) to establish the genetic identity of the cell line and to confirm its clonal origin. We compare the STR profile of the MCB, WCB, and production cells to ensure that no cross‑contamination or misidentification has occurred. This method is also used to confirm that the cell line maintains its identity across passages.

2.4 Karyotyping and Fluorescence In‑Situ Hybridisation (FISH) – Chromosomal Stability
We perform G‑banded karyotyping to detect any numerical or structural chromosomal aberrations (e.g., translocations, deletions, aneuploidy). We analyse at least 20 metaphase spreads per sample, and we report the karyotype according to the ISCN (International System for Human Cytogenomic Nomenclature). For targeted analysis, we use FISH with probes specific to the transgene or to chromosomal regions of interest (e.g., centromeric or telomeric regions) to detect any chromosome‑level changes that may affect stability.

2.5 Array‑Based Comparative Genomic Hybridisation (aCGH) – Genome‑Wide Copy Number Variations
We use array‑CGH to detect sub‑chromosomal copy number variations (CNVs) across the entire genome at high resolution (e.g., 60‑90K probes). This method is more sensitive than karyotyping for detecting small deletions or amplifications, and it can identify regions of loss of heterozygosity (LOH) that may indicate chromosomal instability. We provide a genome‑wide CNV profile and a list of any significant aberrations, with a comparison between the MCB and the production cells.

2.6 Whole‑Genome Sequencing (WGS) – Comprehensive Mutation Detection
We offer WGS at high coverage (≥ 30x) to detect all types of genetic changes, including single nucleotide variants (SNVs), small insertions/deletions (indels), structural variants (SVs), and complex rearrangements. Our bioinformatics pipeline includes stringent quality filtering, variant calling (using GATK or similar), and annotation to identify any mutations that fall within coding regions, regulatory elements, or splice sites. We provide a comprehensive report with a list of all detected variants, the functional impact, and a comparative analysis between the MCB and the production cell sample. This is the most comprehensive approach for genetic stability assessment and is increasingly required for high‑risk products.

2.7 Optical Genome Mapping (OGM) – Detection of Large Structural Variants
We use optical genome mapping (OGM) (e.g., Bionano Saphyr) to detect large structural variants (> 500 bp), including insertions, deletions, inversions, translocations, and duplications, that may be missed by short‑read sequencing. OGM provides a long‑range view of the genome and is particularly useful for detecting complex rearrangements in repetitive regions. We provide a genome‑wide structural variant map and a comparison of the MCB and production samples.

3. Advanced Capabilities – Method Development, Validation, and Regulatory Submission Support

For clients requiring a high‑level validation or a customised genetic stability approach, we offer a suite of customised, research‑grade services that go beyond routine testing:

3.1 Comprehensive Method Validation (ICH Q2(R1) and ICH Q5B Compliant)
We conduct full method validation for each genetic stability assay, including: (a) specificity (ability to distinguish the target sequence from related sequences); (b) linearity (for quantitative assays); (c) accuracy (by spike‑and‑recovery experiments using a reference material); (d) precision (repeatability and intermediate precision); (e) limit of detection (LOD) and limit of quantification (LOQ); and (f) robustness to variations in assay conditions. The validation report is structured to support regulatory submissions.

3.2 Integration Site Analysis and Characterisation (for Targeted Integration)
For cell lines generated by targeted integration (e.g., using CRISPR/Cas9, transposases, or site‑specific recombinases), we perform integration site analysis using targeted locus amplification (TLA) or inverse PCR followed by Sanger or next‑generation sequencing. We confirm the precise location of the transgene integration, the presence of any unintended integrations, and the integrity of the flanking sequences.

3.3 Stability of Episomal Vectors – Retention and Replication Assays
For cell lines using episomal vectors (e.g., EBV‑based or oriP‑based), we assess the retention and replication of the episome by performing Southern blot (for the episomal form) and qPCR for copy number over passages. We also perform a loss‑of‑vector stability test by culturing cells in the absence of selective pressure and monitoring the fraction of cells retaining the vector.

3.4 Telomere Length Analysis – Senescence and Replicative Capacity
We use telomere length measurement (by qPCR or by Southern blot using a telomere‑specific probe) to assess the replicative capacity and the risk of senescence in the cell line. This is particularly relevant for stem cells and for cell lines that are expected to have a finite life‑span.

3.5 Comparative Analysis and Trending – Tracking Stability Across Batches
We provide comprehensive trending reports that compare the genetic stability data across multiple batches and passages, using statistical process control (SPC) and other relevant tools. This allows you to identify any early signs of instability and to take proactive measures.

3.6 Regulatory Submission Assistance – Writing and Reviewing Reports
Our experts can help you to draft the genetic stability sections of your regulatory submissions (e.g., INDs, BLAs), including the preparation of the validation reports, the data summaries, and the risk assessments. We ensure that the documentation meets the requirements of the FDA, EMA, and other agencies.

4. Data Integrity, Standardisation, and Comprehensive Reporting

All analyses are conducted under a strict quality management system that includes the use of certified reference materials, routine controls, and participation in proficiency testing (where available). Our reports provide:

• Full method description – including sample preparation, reagents, instruments, and data analysis parameters.
• Detailed results – including raw data, processed data (e.g., copy numbers, variant lists, karyotypes), and graphical representations (e.g., genome‑wide CNV profiles, STR electropherograms).
• Validation data – including the results of the method validation experiments and a statement of the assay’s performance.
• Interpretative comments – on the significance of the results, the consistency with the MCB, and any recommendations for further testing or process adjustments.

Our reports are authored by senior molecular biologists and geneticists who provide not just raw data, but actionable insights to guide your quality and regulatory decisions.

Turnaround times: 2‑3 weeks for targeted assays (Southern blot, qPCR, STR), 3‑4 weeks for aCGH and karyotyping, 4‑6 weeks for WGS and OGM, and 2‑3 weeks for method validation. Express services are available for urgent projects.

5. Our Unmatched Expertise – Why Choose Our Laboratory for Genetic Stability Analysis

We are one of the few laboratories that hold ISO/IEC 17025 accreditation and GMP compliance for the full spectrum of genetic stability assays, including both classical and state‑of‑the‑art approaches. Our integrated infrastructure combines molecular biology, cytogenetics, next‑generation sequencing, and bioinformatics – enabling cross‑verification of results and a comprehensive understanding of the genetic landscape of your cell line. Our team comprises PhD‑level geneticists, bioinformaticians, and regulatory specialists with extensive experience in cell line characterisation, method validation, and regulatory submissions, and we have a proven track record of supporting products from early development to commercial launch.

We offer unparalleled flexibility: we accept a wide range of sample types – cell pellets, genomic DNA, or even fresh cultures – and we provide customised sampling kits and transport guidance to preserve DNA integrity. Our secure online portal enables real‑time tracking, access to raw data, and downloadable reports.

Our modular pricing ensures cost‑effectiveness: you select the level of analysis – from a targeted screen to full genome‑wide characterisation – with discounts for routine monitoring programmes and bulk submissions. We also provide training, method transfer, and technical consultancy to help you build or strengthen your internal genetic stability testing capabilities.

With a proven history of serving over 80 clients in the biopharmaceutical and cell therapy sectors, we have enabled our partners to ensure product consistency, achieve regulatory compliance, and accelerate time‑to‑market. We invite you to leverage our expertise for your genetic stability analysis needs.

Contact our technical experts today to discuss your cell line, manufacturing process, and regulatory requirements. We will design a tailored testing plan and provide a detailed proposal within one business day.